Esperion Therapeutics Inc (NASDAQ:ESPR) - Share price


Stock Report

Esperion Therapeutics Inc ESPR

Last Price
$49.01

Day Change
0.37|0.76%

As of 25/06/2019
18:07:47 EDT | USD
Minimum 15 Minutes Delay.

Last Close48.64
Day Range48.53 - 50.15
Mkt Cap1.32Bil
52-Wk Range36.06 - 60.99
Yield %-
ISINUS29664W1053
Volume506,495
P/E-17.89
P/S9.17
P/CF-97.18

Share Price

Financials
201620172018
More ...
Income Statement
Revenue--0.00
Operating Income-76.15-168.98-204.59
Net Income-74.98-166.99-201.81
Basic EPS-3.33-6.98-7.54
Avg. Diluted Shares Outstanding232427
Balance Sheet
Current Assets213.58203.92142.63
Non Current Assets31.6473.910.82
Total Assets245.21277.84143.45
Current Liabilities15.5933.1464.33
Total Liabilities16.6133.1464.33
Total Equity228.60244.6979.12
Cash Flow
Operating Cash Flow-47.73-131.30-148.64
Capital Expenditure-0.09-0.02-0.15
Free Cash Flow-47.82-131.32-148.79

In millions, except "Basic EPS". Currency is USD.

Company Profile

Esperion Therapeutics Inc is a pharmaceutical company focused on developing and commercializing oral, low-density lipoprotein cholesterol, or LDL-C, lowering therapies for the treatment of patients with elevated LDL-C.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

76
Key Stats
More ...
Price/Earning TTM-19.07
Price/Book7.48
Price/Sales TTMInfinity
Rev Growth (3 year avg)0.00
EPS Growth (3 year avg)-
Operating Margin % TTM-Infinity
Net Margin % TTM-Infinity
ROE TTM-124.65
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.